Atypical cytokine release syndrome induced by carboplatin: The first described case report
International Journal of Immunopathology and Pharmacology · 2026
DOI: 10.1177/03946320261472669 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Immunopathology and Pharmacology, 2026. Verfasst von Maria Cruz Torres Górriz und 4 weiteren Autor:innen. Beteiligte Einrichtung: Allergy Department, General University Hospital of Castellón, Castellón, Spain. Hauptthemen laut MEDLINE: Carboplatin, Cytokine Release Syndrome, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Hypersensitivity reactions to carboplatin include type I reactions, mixed reactions, and delayed reactions. Case report We report a case of an atypical cytokine release syndrome induced by carboplatin in a patient with breast carcinoma. Management & outcome The patient developed clinical manifestations consisting of a delayed cytokine release syndrome following administration of carboplatin and paclitaxel. To establish the diagnosis, she underwent a double desensitization protocol over two consecutive days with paclitaxel and carboplatin. A delayed elevation of interleukin-6 after carboplatin supported the diagnosis of an isolated cytokine release syndrome. The patient subsequently continued treatment with paclitaxel through standard infusions and with carboplatin using a desensitization protocol.
Discussion
Cytokine release syndrome associated with carboplatin has been previously reported as occurring immediately after infusion and as part of a mixed phenotype (type I and cytokine release). A delayed-onset cytokine release syndrome induced by carboplatin, occurring outside the context of a mixed reaction, is reported.
Conclusion
Cytokine release syndrome may present as an isolated, delayed reaction following carboplatin infusion. Measurement of interleukin-6 may be a valuable diagnostic tool for confirming the diagnosis of cytokine release syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergy Department, General University Hospital of Castellón, Castellón, Spain.
- Doctoral School, Jaume I University, Castellon de la Plana, Spain.
- FISABIO Foundation Research Group, Valencia, Spain.
- Allergy Department, Castellon Provincial Hospital Consortium, Castellón, Spain.
- Allergy Department, University Clinical Hospital of Valencia, Valencia, Spain.
ORCID-Profile: Maria Cruz Torres Górriz
Zitieren
APA
Torres Górriz, M. C., Borrás Cuartero, J., Bosh Requena, A., Jang, D. T., & Enrique, E. (2026). Atypical cytokine release syndrome induced by carboplatin: The first described case report. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177/03946320261472669
Vancouver
Torres Górriz MC, Borrás Cuartero J, Bosh Requena A, Jang DT, Enrique E. Atypical cytokine release syndrome induced by carboplatin: The first described case report. International Journal of Immunopathology and Pharmacology. 2026. doi:10.1177/03946320261472669
BibTeX
@article{TorresGrriz2026,
author = {Torres Górriz, Maria Cruz and Borrás Cuartero, Julian and Bosh Requena, Anna and Jang, Dah Tay and Enrique, Ernesto},
title = {Atypical cytokine release syndrome induced by carboplatin: The first described case report},
journal = {International Journal of Immunopathology and Pharmacology},
year = {2026},
doi = {10.1177/03946320261472669}
}
EUVIMED